EUVIMEDEUVIMED entdecken
Crossref

Efficacy of a novel hemostatic peptide gel (PuraStat) in preventing bleeding after endoscopic resection of large gastrointestinal lesions: a case series study

P. Andreozzi, M. Diaferia, E. Di Girolamo, C. Civiletti, V. D'angelo, V. Tudisco, V. Lambiase, P. Marone, M. De Bellis

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S403

DOI: 10.1055/s-0044-1783703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von P. Andreozzi und 8 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

A novel synthetic self-assembling peptide (PuraStat; 3-D Matrix, Tokyo, Japan) has been introduced as a hemostatic agent [ 1 ]. This case series aimed to evaluate the clinical efficacy of PuraStat for the prevention of bleeding after endoscopic resection of large gastrointestinal (GI) lesions.

Methods

We retrospectively examined all endoscopic resections of>20 mm lesions using Purastat between April 2019 and November 2023. Patient clinical data, endoscopic procedure data and follow up data were collected. Purastat was applied after endoscopic resection for the prevention of post-procedural bleeding. Post-procedural bleeding was defined as any bleeding occurring after the completion of the procedure necessitating emergency department presentation, hospitalization, or reintervention.

Results

Sixty-three consecutive patients (31 females, mean age 67.1±13.4) were collected. Upper GI lesions were removed in 15 patients, lower GI lesions were removed in 59 patients. Lesions were resected by polipectomy in 22.2% (14/63 patients), EMR in 76.2% (48/63 patients), ESD in 1.6% (1/63 patient). Mean size of resected lesions was 30±14mm. Technical success was achieved in 98.3% (62/63 patients). When Purastat was successfully applied, post-procedural bleeding occurred in 6.4% (4/62 patients). Multivariate analysis showed no significant association between post-procedural bleeding and clinical or endoscopic procedure data.

Conclusions

This is the first report of the use of PuraStat in the prevention of bleeding after endoscopic resection of large GI lesions. This novel peptide gel could represent a promising hemostatic device. However, further prospective studies are needed to confirm its efficacy. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Andreozzi, P., Diaferia, M., Girolamo, E. D., Civiletti, C., D'angelo, V., Tudisco, V., Lambiase, V., Marone, P., & Bellis, M. D. (2024). Efficacy of a novel hemostatic peptide gel (PuraStat) in preventing bleeding after endoscopic resection of large gastrointestinal lesions: a case series study. Endoscopy, 56(S 02 S 02), S403. https://doi.org/10.1055/s-0044-1783703

Vancouver

Andreozzi P, Diaferia M, Girolamo ED, Civiletti C, D'angelo V, Tudisco V, et al. Efficacy of a novel hemostatic peptide gel (PuraStat) in preventing bleeding after endoscopic resection of large gastrointestinal lesions: a case series study. Endoscopy. 2024;56(S 02 S 02):S403. doi:10.1055/s-0044-1783703

BibTeX
@article{Andreozzi2024,
  author = {Andreozzi, P. and Diaferia, M. and Girolamo, E. Di and Civiletti, C. and D'angelo, V. and Tudisco, V. and Lambiase, V. and Marone, P. and Bellis, M. De},
  title = {Efficacy of a novel hemostatic peptide gel (PuraStat) in preventing bleeding after endoscopic resection of large gastrointestinal lesions: a case series study},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S403},
  doi = {10.1055/s-0044-1783703}
}
Kostenlos starten →